2007•Chinese Journal of New Drugs and Clinical RemediesRequires access

Pharmacokinetics of escitalopram in healthy volunteers

Jun Chen

Open publisher page 0 citations

Abstract

AIM:To study the pharmacokinetics of escitalopram in healthy Chinese volunteers.METHODS: The volunteers were given a single oral dose of 5,10 or 20 mg escitalopram for single dose pharmacokinetics, or 10 mg escitalopram tablets once a day for 10-days multidose and steady-state study.The plasma concentrations of escitalopram were determined by a validated HPLC-MS/MS method.The pharmacokinetic parameters were calculated by DAS 2.0 software.RESULTS:The main pharmacokinetic parameters of escitalopram after the single oral dose of 5,10 or 20 mg were as follows:AUC_(0-144) were (219±s 49),(367±60) and (689±174)μg·h·L~(-1),respectively;AUC_(0-∞) (242±64),(414±79) and (745±207)μg·h·L~(-1);c_(max) (5.5±1.0), (8.8±1.3) and (21±6)μg·L~(-1);t_(max) (4±3),(6±3) and (3.0±1.5) h;t_(1/2) (40±11),(48±10) and (37±6) h;MRT (56±13),(63±11) and (51±7) h.The parameters after multidose of 10 mg were as follows:AUC_(0-144) was (914±202)μg·h·L~(-1),AUC_(0-∞) (993±214)μg·h·L~(-1),AUC_(ss) (364±78)μg·h·L~(-1), c_(max)~(ss)(26±4)μg·L~(-1),c_(min)~(ss)(12.4±1.1)μg·L~(-1),c_(av)~(ss)(15±3)μg·L~(-1),DF 0.87±0.22,t_(max) (2.6±1.7) h,t_(1/2) (40±7) h.CONCLUSION:The plasma concentration-time curve of escitalopram is fitted with a two- compartment open pharmacokinetic model.The c_(max) and AUC are proportional with the dose ranged from 5 to 20 mg,respectively,while the t_(max),t_(1/2),and MRT are not affected by the dose.Therefore,the linear pharmacokinetics of escitalopram in human plasma is found in Chinese healthy volunteers.

About this research paper

What this paper is about

AIM:To study the pharmacokinetics of escitalopram in healthy Chinese volunteers.METHODS: The volunteers were given a single oral dose of 5,10 or 20 mg escitalopram for single dose pharmacokinetics, or 10 mg escitalopram tablets once a day for 10-days multidose and steady-state study.The plasma concentrations of escitalopram were determined by a validated HPLC-MS/MS method.The pharmacokinetic parameters were calculated by DAS 2.0 software.RESULTS:The main pharmacokinetic parameters of escitalopram after the single oral dose of 5,10 or 20 mg were as follows:AUC_(0-144) were (219±s 49),(367±60) and (689±174)μg·h·L~(-1),respectively;AUC_(0-∞) (242±64),(414±79) and (745±207)μg·h·L~(-1);c_(max) (5.5±1.0), (8.8±1.3) and (21±6)μg·L~(-1);t_(max) (4±3),(6±3) and (3.0±1.5) h;t_(1/2) (40±11),(48±10) and (37±6) h;MRT (56±13),(63±11) and (51±7) h.The parameters after multidose of 10 mg were as follows:AUC_(0-144) was (914±202)μg·h·L~(-1),AUC_(0-∞) (993±214)μg·h·L~(-1),AUC_(ss) (364±78)μg·h·L~(-1), c_(max)~(ss)(26±4)μg·L~(-1),c_(min)~(ss)(12.4±1.1)μg·L~(-1),c_(av)~(ss)(15±3)μg·L~(-1),DF 0.87±0.22,t_(max) (2.6±1.7) h,t_(1/2) (40±7) h.CONCLUSION:The plasma concentration-time curve of escitalopram is fitted with a two- compartment open pharmacokinetic model.The c_(max) and AUC are proportional with the dose ranged from 5 to 20 mg,respectively,while the t_(max),t_(1/2),and MRT are not affected by the dose.Therefore,the linear pharmacokinetics of escitalopram in human plasma is found in Chinese healthy volunteers.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To study the pharmacokinetics of escitalopram in healthy Chinese volunteers.METHODS: The volunteers were given a single oral dose of 5,10 or 20 mg escitalopram for single dose pharmacokinetics, or 10 mg escitalopram tablets once a day for 10-days multidose and steady-state study.The plasma concentrations of escitalopram were determined by a validated HPLC-MS/MS method.The pharmacokinetic parameters were calculated by DAS 2.0 software.RESULTS:The main pharmacokinetic parameters of escitalopram after the single oral dose of 5,10 or 20 mg were as follows:AUC_(0-144) were (219±s 49),(367±60) and (689±174)μg·h·L~(-1),respectively;AUC_(0-∞) (242±64),(414±79) and (745±207)μg·h·L~(-1);c_(max) (5.5±1.0), (8.8±1.3) and (21±6)μg·L~(-1);t_(max) (4±3),(6±3) and (3.0±1.5) h;t_(1/2) (40±11),(48±10) and (37±6) h;MRT (56±13),(63±11) and (51±7) h.The parameters after multidose of 10 mg were as follows:AUC_(0-144) was (914±202)μg·h·L~(-1),AUC_(0-∞) (993±214)μg·h·L~(-1),AUC_(ss) (364±78)μg·h·L~(-1), c_(max)~(ss)(26±4)μg·L~(-1),c_(min)~(ss)(12.4±1.1)μg·L~(-1),c_(av)~(ss)(15±3)μg·L~(-1),DF 0.87±0.22,t_(max) (2.6±1.7) h,t_(1/2) (40±7) h.CONCLUSION:The plasma concentration-time curve of escitalopram is fitted with a two- compartment open pharmacokinetic model.The c_(max) and AUC are proportional with the dose ranged from 5 to 20 mg,respectively,while the t_(max),t_(1/2),and MRT are not affected by the dose.Therefore,the linear pharmacokinetics of escitalopram in human plasma is found in Chinese healthy volunteers.

Key concepts: Pharmacokinetics, Escitalopram, Pharmacology, Plasma concentration, Chemistry, Medicine, Internal medicine, Hippocampus

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of escitalopram in healthy volunteers — Research Paper | ScholarLens